clopidogrel has been researched along with Cholera Infantum in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 16 (72.73) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; Li, J; Wang, X; Wang, Y; Zhou, T | 1 |
| Hofma, S; Hoogendoorn, M; Kruik-Kollöffel, W; Oortgiesen, B; van der Elst, K; van Roon, E | 1 |
| Chen, J; Chen, SY; Lian, JJ; Luo, TC; Zeng, XQ | 1 |
| Lee, R; Lee, T | 1 |
| Al-Tannir, M; Bahamid, R; Kashour, T | 1 |
| Gargallo, CJ; Lanas, A | 1 |
| Bayon, J; Carrillo, P; CruzGonzalez, I; de la Torre Hernandez, JM; de Leiras, SR; Fernandez-Fernandez, J; Fernandez-Portales, J; Gomez-Jaume, A; Gopar-Gopar, S; Hernandez, F; Lasa, G; Lozano, I; Mañas, P; Pérez-Serradilla, A; Pinar, E; Ruiz-Quevedo, V; Sanchez-Insa, E | 1 |
| Fort, JG; Han, Y; Schofield, D; Tursi, JP; Zhang, W | 1 |
| Lanas, A | 1 |
| Hagenaars, MP; Siersema, PD; Smout, AJ; van Boxel, OS; van Oijen, MG | 1 |
| Chan, FK; Ng, SC | 1 |
| Kwok, CS; Loke, YK; Nijjar, RS | 1 |
| Albuquerque, A; Fontes-Carvalho, R | 1 |
| Hunfeld, NG; Kuipers, EJ; Sturkenboom, MC; Touw, DJ; Valkhoff, VE | 1 |
| Grove, EL; Jørgensen, NR; Schwarz, P; Vestergaard, P; Würtz, M | 1 |
| Araki, H; Suemaru, K; Tanaka, A; Tanaka, M | 1 |
| Antonino, M; Bliden, KP; Chai, S; Fort, JG; Gesheff, M; Gesheff, T; Gurbel, PA; Jeong, YH; Shuldiner, A; Tantry, US; Zhang, Y | 1 |
| Devière, J; Hittelet, A | 1 |
| Gray, CS; Morton, JA; Newton, J | 1 |
| Goldhaber, SZ; Vallurupalli, NG | 1 |
| Boissel, JP; Gent, M; Harker, LA; Pilgrim, AJ | 1 |
| Kurz, HI; Lasala, JM; Taniuchi, M | 1 |
8 review(s) available for clopidogrel and Cholera Infantum
| Article | Year |
|---|---|
[Proton pump inhibitors when using clopidogrel: balance between necessity and disadvantages].
Topics: Aspirin; Clopidogrel; Drug Interactions; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors | 2019 |
Pharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in vivo--a systematic review.
Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Drug Resistance; Gastrointestinal Diseases; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Receptors, Purinergic P2Y12; Ticlopidine | 2013 |
Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Ticlopidine | 2015 |
NSAID-induced gastrointestinal and cardiovascular injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 2 Inhibitors; Drug Interactions; Gastrointestinal Diseases; Histamine H2 Antagonists; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Assessment; Ticlopidine | 2010 |
Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis.
Topics: Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2011 |
[Clopidogrel--proton pump inhibitors drug interaction: implications to clinical practice].
Topics: Clopidogrel; Drug Interactions; Gastrointestinal Diseases; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2010 |
Management of anticoagulants before and after endoscopy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Clopidogrel; Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Heparin; Heparin, Low-Molecular-Weight; Humans; Plasma; Postoperative Care; Preoperative Care; Ticlopidine; Vitamin K; Warfarin | 2003 |
Gastrointestinal complications of dual antiplatelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Gastrointestinal Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
4 trial(s) available for clopidogrel and Cholera Infantum
| Article | Year |
|---|---|
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority ra
Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Gastrointestinal Diseases; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome | 2023 |
Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Topics: Administration, Oral; Adult; Aspirin; Clopidogrel; Coronary Thrombosis; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Follow-Up Studies; Gastrointestinal Diseases; Humans; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Ticlopidine; Treatment Outcome | 2013 |
Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events.
Topics: Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopidogrel; Double-Blind Method; Gastrointestinal Diseases; Hemorrhage; Humans; Myocardial Infarction; Neutropenia; Platelet Aggregation Inhibitors; Stroke; Thrombocytopenia; Ticlopidine; Time Factors; Treatment Outcome | 1999 |
Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population.
Topics: Abciximab; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Coronary Thrombosis; Eptifibatide; Exanthema; Female; Gastrointestinal Diseases; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Neutropenia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine | 2001 |
10 other study(ies) available for clopidogrel and Cholera Infantum
| Article | Year |
|---|---|
Ask the doctor. I need surgery for a gastrointestinal problem, and my question is how to handle my antiplatelet therapy, which I have been taking for two years since I had angioplasty. I take aspirin and clopidogrel, which were started after I had a hea
Topics: Aspirin; Clopidogrel; Contraindications; Digestive System Surgical Procedures; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Humans; Platelet Aggregation Inhibitors; Preoperative Care; Stents; Ticlopidine; Withholding Treatment | 2012 |
Changing prescription pattern of omeprazole among patients receiving clopidogrel.
Topics: Clopidogrel; Drug Interactions; Drug Prescriptions; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Diseases; Humans; Myocardial Ischemia; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Ticlopidine | 2014 |
Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Male; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome | 2016 |
The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.
Topics: Adult; Aged; Aspirin; Budgets; Cardiovascular Diseases; Clopidogrel; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Male; Markov Chains; Medication Adherence; Middle Aged; Models, Econometric; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Secondary Prevention; Ticlopidine | 2017 |
[Proton pump inhibitors and clopidogrel in a patient with cardiovascular risk factors: Cardiovascular versus gastrointestinal risk?].
Topics: Algorithms; Cardiovascular Diseases; Clopidogrel; Gastrointestinal Diseases; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Ticlopidine | 2010 |
Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Clopidogrel; Databases, Factual; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Netherlands; Platelet Aggregation Inhibitors; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome | 2010 |
[Clopidogrel and proton pump inhibitors: insufficient evidence of interaction].
Topics: Aryl Hydrocarbon Hydroxylases; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Gastrointestinal Diseases; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2011 |
Gastrointestinal events with clopidogrel: a nationwide population-based cohort study.
Topics: Aged; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Denmark; Dose-Response Relationship, Drug; Drug Utilization; Female; Gastritis; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine | 2013 |
The assessment of risk for gastrointestinal injury with anticoagulant and antiplatelet drugs: the possible beneficial effect of eicosapentaenoic Acid for the risk of gastrointestinal injury.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Eicosapentaenoic Acid; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Agents; Retrospective Studies; Risk Assessment; Ticlopidine; Warfarin | 2013 |
Counting the true cost of antiplatelet therapy for stroke prevention.
Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Male; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; United Kingdom | 2005 |